U.S. COVID-19 Update eNewsletter
September 21, 2021

Monoclonal Antibodies "Underutilized" for Treating, Preventing COVID-19
Pharmacists are urged to take a more active role in counseling COVID-19 patients and those at high risk of infection complications on the use of monoclonal antibodies for treatment and prevention of the novel coronavirus infection. Three products are approved for that purpose, but public health officials decry their underutilization. Here is more information.


Advertisement

Vaccines Prevented Nearly 140,000 COVID-19 Deaths Early in the Campaign
Even early in the U.S. vaccine campaign, nearly 140,000 lives were saved by administering COVID-19 shots, according to a new study. How much mortality rates were reduced, and how quickly, varied substantially among states, however. Find out which ones were most affected.



Pfizer COVID-19 Shot has EUA for Ages 12-15 Years; Not Approved for Younger Children
Pharmacists are getting a lot of questions from parents and caregivers confused about COVID-19 shots for their children, FDA approval of the Pfizer-BioNTech product only for those 16 and older might have added to the confusion. Here is information about what age children can get the shots, and recent CDC data on safety of the vaccine.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement